Youngone (111770)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 69,000.00 |
|---|---|
| 52-week range | 56,800.00 – 103,200.00 |
| Return, 1 month / 3 months | −0.4% / −20.1% |
| Return, 1 year / 3 years | +17.0% / +44.7% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 50.8% |
| Worst drawdown (1 year) | -30.9% |
| Average daily value traded | 5,400.34M KRW |
| Dividend yield | 3.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Youngone is a South Korean company that makes outdoor clothing and equipment. It produces jackets, pants, backpacks, tents and other gear for outdoor and athletic brands, and it also runs its own outdoor apparel labels. Its customers are mainly international brands and retailers that source finished garments and equipment from its factories, which are located in Asia. The company is based in Korea and serves markets around the world.
On this site Youngone appears as a stock on the Korea Stock Exchange (Korea), code 111770, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Youngone (111770) trades on the Korea Stock Exchange in Korea. It last closed at KRW 69,000.00 on 23 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 279 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.0% and over the last three months it fell 20.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -14.7% | ||
| From 52-week high | -29.6% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -20.1% | ||
| 6-month return | -16.7% | ||
| 12-month return, skipping the last month | 17.5% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 50.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.9% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 5,400.34M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 73 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.6% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −7.1% |
|---|---|
| 1 month | −0.4% |
| 3 months | −20.1% |
| 6 months | −16.7% |
| 1 year | +17.0% |
| 3 years | +44.7% |
| 5 years | +76.4% |
Signals
| 50-day / 200-day average | 74,167.23 / 80,867.01 |
|---|---|
| Golden / death cross (60 days) | Death, 41 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2,844.37 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Aug 2026 | KRW 1,050.0000 |
| 29 Dec 2025 | KRW 1,400.0000 |
| 8 Sep 2025 | KRW 700.0000 |
| 27 Dec 2024 | KRW 1,400.0000 |
| 27 Dec 2023 | KRW 1,300.0000 |
| 28 Dec 2022 | KRW 1,530.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.